1-Jahres-Chart (nicht börsennotiert)
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,015 | 22.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 14.02.2024 | 450 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 14.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 14.02.2024ISIN Name
BE0974429624... ► Artikel lesen | |
| 19.05.23 | XFRA 8E70: AUSSETZUNG/SUSPENSION | 583 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPHARMASIMPLE S.A.... ► Artikel lesen |
2 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INNOCAN PHARMA | 0,191 | -0,26 % | Ausbruch - startet jetzt die massive FDA-Rallye? | ||
| SYNBIOTIC | 9,880 | -3,14 % | "Wollen die erfolgreichste paneuropäische Hanf- und Cannabis-Holding aufbauen" - Interview mit Daniel Kruse, SynBiotic SE | SYNBIOTIC ist eine börsennotierte Unternehmensgruppe (ISIN: DE000A3E5A59), die sich auf die umfassende Nutzung des Potenzials der Hanf- und Cannabispflanze spezialisiert hat. Zum weiteren Unternehmenswachstum... ► Artikel lesen | |
| BIONANO GENOMICS | 0,800 | +0,70 % | Bionano Genomics: Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing | SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping... ► Artikel lesen | |
| AXSOME THERAPEUTICS | 67,06 | -1,82 % | Axsome Therapeutics, Inc.: Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting | AXS-05 in Alzheimer's disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in pooled analysis Presentations on cognitive and wake promoting... ► Artikel lesen | |
| ENDO INTERNATIONAL | 0,010 | 0,00 % | Endo, Inc. Completes Acquisition of Endo International plc's Assets | Newly Formed Company Poised for Sustained Growth With a Strengthened Balance Sheet, Resolved Litigation Overhang, Diversified Portfolio of Medicines and a Deep New Product Pipeline
MALVERN... ► Artikel lesen | |
| TRULIEVE CANNABIS | 9,785 | -1,71 % | Trulieve Cannabis Corp. - 8-K, Current Report | ||
| WEST PHARMACEUTICAL SERVICES | 356,70 | -2,14 % | Dividendenbekanntmachungen (23.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABC ARBITRAGE SA FR0004040608 - 0,1 EUR AECOM US00766T1007 0,22 USD 0,2065 EUR ALLREAL HOLDING AG CH0008837566 3,5 CHF 3,6021... ► Artikel lesen | |
| HERITAGE CANNABIS | 0,001 | 0,00 % | Heritage Cannabis Announces Commencement of Sale and Investment Solicitation Process | Toronto, ON, April 15, 2024 (GLOBE NEWSWIRE) -- Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) ("Heritage" or the "Company") today announced the commencement of a sale and investment... ► Artikel lesen | |
| SHIONOGI | 44,200 | -0,90 % | Dividendenbekanntmachungen (28.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACOM CO LTD JP3108600002 6 JPY 0,0366 EUR ADVANEX INC JP3213400009 20 JPY 0,1222 EUR AICA KOGYO CO LTD JP3100800006 59 JPY 0... ► Artikel lesen | |
| KALA BIO | 6,045 | +5,41 % | KALA BIO, Inc.: KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update | -- Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by year-end 2024 ---- Exploring opportunities to expand KPI-012 into additional corneal indications ---- Cash resources... ► Artikel lesen | |
| THERIVA BIOLOGICS | 0,470 | +34,14 % | Theriva Biologics, Inc.: Theriva Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma | -Phase 1 trial in collaboration with Sant Joan de Déu-Barcelona Children's Hospital (SJD) determined to have a positive outcome by the study Monitoring Committee-
-Safety and clinical outcomes support... ► Artikel lesen | |
| CHARLOTTES WEB | 0,189 | -8,25 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports 2023 Fourth Quarter and Year-End Financial Results | Transforming the consumer journey through eCommerce platform optimizations, brand consolidation, and price recalibrations; While reducing expenses and maintaining gross margins
LOUISVILLE, Colo.... ► Artikel lesen | |
| BEXIMCO | 0,430 | +0,94 % | IN BRIEF: Beximco names Iqbal Ahmed as managing director | ||
| LUYE PHARMA | 0,312 | -1,27 % | LUYE PHARMA (02186): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023 | ||
| NRX PHARMACEUTICALS | 2,930 | 0,00 % | NRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement | The Nasdaq Panel has determined to continue the listing of the Company's securities on The Nasdaq Stock Market and is closing this matter
Four upcoming milestones expected: data from trials in Suicidal... ► Artikel lesen |
PHARMASIMPLE SA gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,008 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
